ArticleLancet (London, England)2020
Encouraging results from phase 1/2 COVID-19 vaccine trials.
Article in Lancet (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Effects of vaccination against COVID-19 on overactive bladder symptoms on young population.Frontiers in medicine · 2024Article
- Structure-guided antibody cocktail for prevention and treatment of COVID-19.PLoS pathogens · 2021Article
- Just a Reflection: Does Drug Repurposing Perpetuate Sex-Gender Bias in the Safety Profile?Pharmaceuticals (Basel, Switzerland) · 2021Review
- Adenovirus and RNA-based COVID-19 vaccines' perceptions and acceptance among healthcare workers in Saudi Arabia: a national survey.BMJ open · 2021Article
- An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology.Journal of the American Academy of Dermatology · 2021Review
- Amantadine Inhibits SARS-CoV-2 In Vitro.Viruses · 2021Article
- Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities.Scientific reports · 2021Article
- Topic detection and sentiment analysis in Twitter content related to COVID-19 from Brazil and the USA.Applied soft computing · 2021Article
- Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy.Communications biology · 2021Article
- Ongoing Clinical Trials of Vaccines to Fight against COVID-19 Pandemic.Immune network · 2021Review
- COVID-19 vaccine confidence and hesitancy among health care workers: A cross-sectional survey from a MERS-CoV experienced nation.PloS one · 2021Article
- Modeling COVID-19 scenarios for the United States.Nature medicine · 2021Article
- Perspective on the Role of Antibodies and Potential Therapeutic Drugs to Combat COVID-19.The protein journal · 2020Review
- Sex-Based Vaccine Response in the Context of COVID-19.Journal of obstetric, gynecologic, and neonatal nursing : JOGNN · 2020Article
- Identification of Small Molecule Inhibitors of the Deubiquitinating Activity of the SARS-CoV-2 Papain-Like Protease:Frontiers in chemistry · 2020Article
- Virus database annotations assist in tracing information on patients infected with emerging pathogens.Informatics in medicine unlocked · 2020Article
- Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality.Frontiers in immunologyReview
Corrections and comments
- Comment on
- Comment on
- Erratum issued
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.